Byens Kiropraktor Aps

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  20.5% 8.4% 7.3% 21.6% 17.2%  
Credit score (0-100)  6 30 33 4 9  
Credit rating  B BB BBB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  356 0 288 0 0  
Gross profit  131 0.0 22.1 -64.3 0.0  
EBITDA  102 146 22.1 -64.3 -3.1  
EBIT  45.1 74.3 22.1 -64.3 -3.1  
Pre-tax profit (PTP)  44.9 74.1 22.1 -64.3 -3.1  
Net earnings  30.7 74.1 22.1 -76.3 -3.1  
Pre-tax profit without non-rec. items  44.9 74.1 22.1 -64.3 -3.1  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Tangible assets total  171 142 56.9 0.0 0.0  
Shareholders equity total  1.7 73.5 95.7 19.4 20.6  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  245 232 159 41.5 20.6  

Net Debt  -48.9 -64.6 -102 -41.5 -12.2  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  356 0 288 0 0  
Net sales growth  0.0% -100.0% 0.0% -100.0% 0.0%  
Gross profit  131 0.0 22.1 -64.3 0.0  
Gross profit growth  7.8% -100.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  -9.7 -13.6 0.0 0.0 -3.1  
Balance sheet total (assets)  245 232 159 42 21  
Balance sheet change%  -37.0% -5.2% -31.6% -73.8% -50.3%  
Added value  111.8 159.3 22.1 -64.3 0.0  
Added value %  31.3% 0.0% 7.7% 0.0% 0.0%  
Investments  -114 -100 -85 -57 0  

Net sales trend  0.0 -1.0 0.0 -1.0 0.0  
EBIT trend  2.0 3.0 4.0 -1.0 -2.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  28.6% 0.0% 7.7% 0.0% 0.0%  
EBIT %  12.7% 0.0% 7.7% 0.0% 0.0%  
EBIT to gross profit (%)  34.4% 0.0% 100.0% 100.0% 0.0%  
Net Earnings %  8.6% 0.0% 7.7% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  24.6% 0.0% 7.7% 0.0% 0.0%  
Pre tax profit less extraordinaries %  12.6% 0.0% 7.7% 0.0% 0.0%  
ROA %  12.7% 31.1% 11.3% -64.2% -10.1%  
ROI %  5,168.4% 166.0% 24.1% -111.7% -15.7%  
ROE %  15.7% 196.9% 26.2% -132.5% -15.7%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  0.7% 31.7% 60.3% 46.8% 100.0%  
Relative indebtedness %  68.2% 0.0% 21.9% 0.0% 0.0%  
Relative net indebtedness %  54.5% 0.0% -13.5% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -47.9% -44.3% -460.0% 64.6% 386.9%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  0.2 0.4 1.6 1.9 0.0  
Current Ratio  0.2 0.4 1.6 1.9 0.0  
Cash and cash equivalent  48.9 64.6 101.9 41.5 12.2  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  599.6 0.0 0.0 0.0 0.0  
Current assets / Net sales %  13.7% 0.0% 35.4% 0.0% 0.0%  
Net working capital  -194.4 -79.9 38.8 19.4 20.6  
Net working capital %  -54.5% 0.0% 13.5% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0